Scoping review of factors influencing chemotherapy-related cognitive impairment in cancer patients
10.3760/cma.j.cn115682-20231120-02152
- VernacularTitle:肿瘤患者化疗相关认知障碍影响因素的范围综述
- Author:
Xiucen WU
1
;
Guihua CHEN
;
Qin LI
;
Huan TANG
Author Information
1. 重庆医科大学附属第二医院呼吸内科，重庆 400010
- Keywords:
Review;
Neoplasms;
Chemotherapy-related cognitive impairment;
Research status;
Assessment tool;
Influencing factors analysis
- From:
Chinese Journal of Modern Nursing
2024;30(22):3052-3057
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To provide a scoping review of the assessment tools and influencing factors of chemotherapy-related cognitive impairment (CRCI) in cancer patients and offer insights for developing personalized intervention methods.Methods:Guided by the scoping review methodology proposed by the Joanna Briggs Institute (JBI) in Australia, a comprehensive search was conducted in databases such as CNKI, Wanfang, VIP, SinoMed, PubMed, CINAHL, Embase, Cochrane Library, and Web of Science. The type of literature searched include cross-sectional studies, cohort studies, and case-control studies from the inception of the databases to July 2023, focusing on the factors influencing CRCI in cancer patients. Data extraction, collection, summarization, and reporting of research results were performed for the included studies.Results:A total of 14 studies were included. The influencing factors of CRCI in cancer patients identified were age, gender, fatigue level, anxiety and depression, nutritional status, educational level, number of chemotherapy sessions and exercise.Conclusions:CRCI is a common issue among cancer patients and is influenced by multiple complex factors. Healthcare professionals can develop risk screening tools for CRCI based on these factors, allowing for timely and precise preventive and therapeutic measures for patients at risk, ultimately improving their quality of life and self-efficacy.
